NTR-1011
/ Neutrolis
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 21, 2025
LIBERATEI: Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA
(clinicaltrials.gov)
- P1 | N=48 | Recruiting | Sponsor: Neutrolis
New P1 trial • Immunology • Inflammatory Arthritis • Lupus • Rheumatoid Arthritis • Rheumatology • Systemic Lupus Erythematosus
1 to 1
Of
1
Go to page
1